Reaccreditation process for colposcopists

The reaccreditation cycle for colposcopists for the period 2021-2024 has now closed. If you are a colposcopist and ahave not had an opportunity to reaccredit this is still possible using the alternative process of the over four years pathway. Check the link below for more information.

From 2023 this will be processed via an automated certification within the BSCCP learning zone. All accredited colposcopists will automatically be enrolled in this process which will appear as a current learning item within the Learning zone after the 1st of September 2024.

Attend a BSCCP recognised meeting post graduate meeting in colposcopy.

Not all courses/meetings are suitable for reaccreditation. It is imperative that you ensure the meeting you are attending is recognised for reaccreditation. These are marked on the label of the events on the events page below. If you are in any doubt, please contact the BSCCP office to clarify.

The online form must be completed from within your BSCCP learningzone account after the 1st September 2024 for the process of reaccreditation to be complete.

The minimum caseload will be 50 NEW colposcopy cases in a continuous 12 month period in the preceding 3 years at the time of submission which can be made up as follows:

• A minimum of 25 new cases with abnormal cytology
• A maximum of 25 new cases referred with the following

• Abnormal symptoms
• Abnormal appearing cervix
• Multi focal lower genital tract disease
• Referrals within or between colposcopy clinics.

• Referral Smear - The number of new patient colposcopies you have seen during this 12 month period (no follow up patients). A minimum of 25 must have been referred with abnormal screening results only.
• Biopsy - refers to either punch biopsy, loop diathermy excision or any other excisional procedure which results in histological assessment of the cervix, including cone biopsy or hysterectomy. Any biopsy, whether or not this is performed in the Colposcopy Clinic, represents a biopsy for the purposes of this form.
• Adequate for histology - if the histology report states that the specimen is inadequate for assessment, the sample should be classified as inadequate for the purposes of this form (irrespective of whether a biopsy was performed).
• Histology results - this refers to the numbers of specimens that have CIN reported on histology (this does not include basal layer atypia).